Skip to content

Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia

Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06476223
Enrollment
26
Registered
2024-06-26
Start date
2024-07-01
Completion date
2025-01-31
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia

Brief summary

Hemodialysis patients with xerostomia are divided into 2 groups which are group A (start with artificial saliva containing cumin and ginger extract for 2 weeks, free periods 2 weeks, then placebo for 2 weeks) and group B (start with placebo for 2 weeks, free periods 2 weeks, then artificial saliva containing cumin and ginger extract for 2 weeks). Amount of saliva (g/min), xerostomia's questionnaire, Increase of saliva score, World Health Organization Oral Mucositis Grading Scale, acid and base of saliva, quality of life's questionnaire will measure before, after using the sample for 7 and 14 days.

Interventions

The sample will be sprayed 2 puff/time, 3 times/day, for 14 days.

DRUGPlacebo

The sample will be sprayed 2 puff/time, 3 times/day, for 14 days.

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age more than 18 years * Hemodialysis patients with xerostomia (saliva flow rate less than 0.2 g/min) * Hemodialysed history more than 3 months * Be willing to participate in the study

Exclusion criteria

* Patients with sialolith or Sjogren's syndrome * Uncontrolled other diseases * Using artificial saliva for more than 2 weeks * Taking pilocarpine and cevimeline * Allergic to ginger, cumin, xylitol, and glycerin * Have mucositis * Pregnancy or lactation

Design outcomes

Primary

MeasureTime frameDescription
Xerostomia symptoms using Xerostomia Inventory Score14 daysPatients give the score of Xerostomia Inventory questionnaire. The Xerostomia Inventory Score is graded 11 to 55 (Low score means low frequency xerostomia and high score means high frequency of xerostomia)

Secondary

MeasureTime frameDescription
Salivary flow rate14 daysWeigh the saliva amount from the patients in 5 mins and then calculate in g/min
Amount of saliva score14 daysPatients give the score of saliva amount (0 to 10, 0 means no saliva and 10 means high amount of saliva)
Quality of life score using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 3514 daysPatients give the score of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35. The score is graded 35 to 130 (Low score means high quality of life and high score means low quality of life)
World Health Organization Oral Mucositis14 daysWorld Health Organization Oral Mucositis is graded 0 to 4 (0 means no mucositis to 4 means severe mucositis).
Acid and base of saliva14 daysMeasure acid and base of saliva using acid and base standard paper

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026